Release Date: 30/09/14 18:29 Summary: Ceasing to be a substantial holder from MLM Price Sensitive: No Download Document 61.41KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%